| Literature DB >> 28233697 |
A Huertas1, S Oldrini2, J-P Nesseler2, F Courrech2, P Rétif3, C Charra-Brunaud2, D Peiffert2.
Abstract
The treatment of cervical cancers according to FIGO staging is well defined. For FIGO stage IB2 or more, chemoradiotherapy followed by uterovaginal brachytherapy boost is the standard treatment. Surgery is the preferred choice for less advanced tumors. However, most French institutions propose preoperative brachytherapy followed by hysterectomy with pelvic lymphadenectomy for FIGO stage IB1 tumors over 2cm. Brachytherapy is also used for the boost after adjuvant pelvic external beam radiotherapy. Tridimensional dosimetry with optimization allows better treatment planning, delivering high doses to target volumes with limited irradiation to the organs at risk. We will discuss the indications of brachytherapy for FIGO stage IB1 tumors and the principles of pulsed-dose rate and high-dose rate techniques.Entities:
Keywords: Brachytherapy; Cancer du col utérin; Cervical cancer; Colpohystérectomie; Curiethérapie; HDR; Hysterectomy; Optimization; PDR
Mesh:
Year: 2017 PMID: 28233697 DOI: 10.1016/j.canrad.2016.09.014
Source DB: PubMed Journal: Cancer Radiother ISSN: 1278-3218 Impact factor: 1.018